[go: up one dir, main page]

MX9300707A - Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion. - Google Patents

Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion.

Info

Publication number
MX9300707A
MX9300707A MX9300707A MX9300707A MX9300707A MX 9300707 A MX9300707 A MX 9300707A MX 9300707 A MX9300707 A MX 9300707A MX 9300707 A MX9300707 A MX 9300707A MX 9300707 A MX9300707 A MX 9300707A
Authority
MX
Mexico
Prior art keywords
topical
pct
liposomatic
compositions
procedure
Prior art date
Application number
MX9300707A
Other languages
English (en)
Inventor
Giovanni Lucchetti
Giuseppe Assogna
Pietro Bagnato
Original Assignee
Janssen Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Farmaceutici Spa filed Critical Janssen Farmaceutici Spa
Publication of MX9300707A publication Critical patent/MX9300707A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una formulación liposomática tópica que comprende piroxicam, un fosfolípido, un sistema solvente para piroxicam y dicho fosfolípido, agua y agentes de formulación auxiliares, convencionales, y un método para preparar dicha formulación.
MX9300707A 1992-02-12 1993-02-10 Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion. MX9300707A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200398 1992-02-12

Publications (1)

Publication Number Publication Date
MX9300707A true MX9300707A (es) 1994-01-31

Family

ID=8210420

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300707A MX9300707A (es) 1992-02-12 1993-02-10 Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion.

Country Status (13)

Country Link
US (1) US5505960A (es)
JP (1) JPH07503952A (es)
CN (1) CN1075633A (es)
AT (1) ATE137959T1 (es)
AU (1) AU661755B2 (es)
CA (1) CA2129624A1 (es)
DE (1) DE69302677T2 (es)
DK (1) DK0625898T3 (es)
ES (1) ES2090966T3 (es)
IL (1) IL104688A0 (es)
MX (1) MX9300707A (es)
TW (1) TW262382B (es)
ZA (1) ZA93954B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085414A2 (en) * 2000-12-19 2002-10-31 The Board Of Regents Of The University Of Texas System Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
WO2005011708A1 (en) * 2003-07-31 2005-02-10 The Board Of Regents Of The University Of Texas System Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
EP2010180A4 (en) 2006-04-21 2010-10-13 Glaxosmithkline Llc IL-8 RECEPTOR ANTAGONISTS
US8772358B2 (en) * 2008-11-12 2014-07-08 Archer Daniels Midland Co. Lecithin and plasticizer compositions and methods
CN101637451B (zh) * 2009-06-12 2011-03-30 陶灵刚 一种氯诺昔康脂质体药物组合物及其固体制剂
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
US8871811B2 (en) 2011-02-07 2014-10-28 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US8906397B2 (en) 2011-02-07 2014-12-09 Professional Compounding Centers of America, Ltd Permeation enhancers for topical formulations
US20120201871A1 (en) * 2011-02-07 2012-08-09 Professional Compounding Centers Of America, Ltd. Permeation enhancers with liposomes for topical formulations
MX340951B (es) 2011-09-29 2016-07-29 Plx Pharma Inc Portadores dependientes del ph para la liberacion dirigida de productos farmaceuticos a lo largo del tracto gastrointestinal, composiciones de los mismos, y fabricación y uso de las mismas.
US9415054B2 (en) 2013-06-13 2016-08-16 Professional Compounding Centers Of America (Pcca) Piroxicam transdermal composition to treat plantar fasciitis
MX2022011743A (es) 2020-03-26 2022-12-08 Plx Opco Inc Portadores farmaceuticos con capacidad de reconstitucion dependiente del ph y metodos para elaborar y usar los mismos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
DE3778972D1 (de) * 1986-06-12 1992-06-17 Liposome Co Inc Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
BE1000381A4 (fr) * 1987-03-13 1988-11-16 Pharlyse Sa Preparation pharmaceutique a base d'indometacine.
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
AU3495093A (en) 1993-09-03
AU661755B2 (en) 1995-08-03
DK0625898T3 (da) 1996-06-03
CA2129624A1 (en) 1993-08-19
DE69302677T2 (de) 1996-10-02
JPH07503952A (ja) 1995-04-27
CN1075633A (zh) 1993-09-01
ES2090966T3 (es) 1996-10-16
US5505960A (en) 1996-04-09
ATE137959T1 (de) 1996-06-15
DE69302677D1 (de) 1996-06-20
IL104688A0 (en) 1993-06-10
TW262382B (es) 1995-11-11
ZA93954B (en) 1994-08-11

Similar Documents

Publication Publication Date Title
AU6062296A (en) Lipids for epidermal moisturization and repair of barrier function
MX9300707A (es) Composiciones liposomaticas topicas que comprenden piroxicam y procedimiento para su preparacion.
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ATE296612T1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2149340T3 (es) Disacaridos de glucosamina, metodo para su preparacion, composicion farmaceutica que los comprende, y su uso.
MX9300708A (es) Composiciones liposomaticas topicas que comprenden itraconazol y procedimiento para su preparacion.
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
ES2039292T3 (es) Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.
MX9301723A (es) Derivados de carbinol di-arilo puenteados, composiciones y metodos de uso.
DE50000033D1 (de) Haarwaschmittel
GR3023677T3 (en) Neutral auto-gloss emulsion for the maintenance of floors (iii).
DK0632717T3 (da) Middel til anvendelse som et anti-irritationsmiddel
MX9307736A (es) Nuevas triazoloquinazolinas, su obtencion y uso.